Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

Clinical trial NCT01182168 · COMPLETED

Trial details

NCT number: NCT01182168
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Bladder Cancer Renal Pelvis Cancer Ureter Cancer

Start date: 2010-08-01
Primary completion: 2016-03-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.